Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Dosing at Planned Cesarean Section
NCT03361124Phase 4Withdrawn
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Peptides
01
Overview
A Phase 4 trial of oxytocin in postpartum hemorrhage (PPH), uterine atony, sponsored by Penn State Health Milton S. Hershey Medical Center. Planned start Mar 2019; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT03361124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361124.